A.   Relief of pain

B.   Increased urine specific gravity

C.   Decreased adrenocorticotropic hormone levels

D.   Increased serum albumin levels

A.   Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

B.   Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

C.   Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

D.   Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

A.   Somatropin

B.   Somatolactin

C.   Choriomammotropin

D.   Somatostatin

A.   Oxytocin

B.   Cosyntropin

C.   Vasopressin

D.   Octreotide

A.   Hypopituitary dwarfism

B.   Polyuria

C.   Polydipsia

D.   Acromegaly

A.   Desmopressin

B.   Luteinizing hormone

C.   Vasopressin

D.   Somatropin

A.   Uric acid level

B.   Blood glucose level

C.   Creatinine clearance test

D.   Complete blood count result

A.   Demeclocycline

B.   Carbamazepine

C.   Ciprofloxacin

D.   Cyclosporine

A.   Cosyntropin

B.   Octreotide

C.   Oxytocin

D.   Thyroid hormone

A.   Polydipsia

B.   Polyuria

C.   Dehydration

D.   Headache

A.   Desmopressin

B.   Cosyntropin

C.   Octreotide

D.   Somatropin

A.   Desmopressin

B.   Octreotide

C.   Somatropin

D.   Vasopressin

A.   Causes prolongation of QT interval

B.   Reduces the effects of desmopressin

C.   Enhances the effects of desmopressin

D.   Produces an additive effect

A.   Hypotension

B.   Inflammation

C.   Edema

D.   Scar formation

A.   Constipation, Malaise, Hypercalciuria

B.   Dyspnea, Constipation, Hypercalciuria

C.   Malaise, Dyspnea,

D.   Arthralgia, Hypercalciuria, Constipation

A.   Liver enzyme levels, Renal function studies, Weight

B.   Renal function studies, Liver enzyme levels, Blood pressure

C.   Weight, Blood pressure, Blood glucose levels

D.   Liver enzyme levels, Blood glucose levels, Renal function studies

A.   Thioridazine

B.   Norepinephrine

C.   Acetaminophen

D.   Carbamazepine

A.   Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

B.   Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

C.   Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

D.   Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

A.   Decreases growth

B.   Reduces weight loss

C.   Reduces fat levels

D.   Decreases fluid retention

A.   Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

B.   Diabetes insipidus, Seizure, Type I von Willebrand

C.   Asthma, Diabetes insipidus, Type I von Willebrand

D.   Seizure, Asthma, Cardiovascular disease

A.   Fludrocortisone

B.   Glucocorticoids

C.   Ciprofloxacin

D.   Cyclosporine

A.   Hyperglycemia

B.   Hyponatremia

C.   Hypokalemia

D.   Orthostatic hypotension

A.   Hypoglycemia

B.   Heartburn

C.   Edema

D.   Seizures

A.   Vasopressin and carbamazepine

B.   Desmopressin and carbamazepine

C.   Vasopressin and demeclocycline

D.   Somatropin and glucocorticoids

A.   A 7-year-old diagnosed with growth hormone deficiency

B.   A 10-year-old of short stature who has severe asthma

C.   A 17-year-old who is 5 feet tall

D.   An 8-year-old with a pituitary tumor

A.   Cachexia and closed growth plates

B.   Human immunodeficiency virus (HIV) infection

C.   Bilateral metastatic breast cancer

D.   Acute bronchitis with laryngitis

A.   Loss of consciousness

B.   Abundant, diluted urine

C.   Oozing blood

D.   Watery diarrhea

A.   "Shake the drug preparation thoroughly before use."

B.   "Inhale the drug preparation by spraying into the nostrils."

C.   "Dilute the drug preparation before administration."

D.   "Apply the drug preparation topically to the nasal membranes."

A.   Hyperglycemia

B.   Hypercalciuria

C.   Hypothyroidism

D.   Hypertension

A.   Pressing the pump once to spray a 10-mcg dose

B.   Replacing the cap on the pump after the procedure

C.   Pressing down on the pump two times to prime it

D.   Priming the nasal pump once a week

A.   Height, Weight, Motor skills

B.   Weight, Skin turgor, Visual acuity

C.   Motor skills, Visual acuity, Skin turgor

D.   Skin turgor, Height, Visual acuity

A.   "Is there any change in the color of your sputum?" "Do you have excessive bleeding due to minor injuries?"

B.   "Is there any change in the color of your urine?" "Is there any change in the color of your sputum?"

C.   "Do you feel very thirsty lately?" "How many times do you urinate in a day?"

D.   "Do you have excessive bleeding due to minor injuries?" "Is there any change in the color of your urine?"

A.   Inhaling the medication into the airway

B.   Administering half the dose in each nostril

C.   Priming the pump each week

D.   Storing the pump at room temperature

A.   The patient needs to adjust fluid intake.

B.   The medication is not effective for this condition.

C.   A higher dose of medication is required for treatment.

D.   The patient is stable and needs reassurance.

A.   Fatigue, Headache

B.   Joint pain, Fatigue

C.   Headache, Joint pain

D.   Diarrhea, Flushing

A.   Patient C: VIP; life-threatening hypotension; diarrhea and flushing

B.   Patient B: carcinoid tumor; taking ciprofloxacin

C.   Patient A: esophageal varices; type 1 diabetes

D.   Patient D: VIP; severe diarrhea and flushing; renal impairment

A.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Replace the cap on the bottle. 5. Give half a spray in each nostril. 6. Monitor the level of drug left in the pump.

B.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

C.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Monitor the level of drug left in the pump. 6. Replace the cap on the bottle.

D.   1. Clear the nasal passages. 2. Give half a spray in each nostril. 3. Place the spray nozzle in the nostril. 4. Prime the pump by pressing down four times. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

A.   Esophageal varices and a history of type 2 diabetes

B.   Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

C.   Small-bowel fistula and having an acute asthma attack

D.   Acromegaly and a serum creatinine level of 5.0 mg/dL

A.   Make a note of the fluid intake.

B.   Assess for signs of dehydration.

C.   Measure the patient’s urine output regularly.

D.   Watch the IV site closely for infiltration.

A.   Edema of the extremities, Elevated blood pressure

B.   Elevated blood pressure, Weight gain

C.   Increased urination, Thirst

D.   Weight gain, Edema of the extremities

A.   Inquire about abdominal discomfort

B.   Monitor for signs of infiltration

C.   Assess the patient for headaches

D.   Notice increase in body temperature

A.   Obtain baseline weight and height measurements

B.   Review the frequency with the health care provider

C.   Calculate the dosage with the pharmacist or another nurse

D.   Review current laboratory values for blood glucose

A.   Growth percentile has increased from the previous annual physical.

B.   Previous somatropin injection site tender to touch.

C.   Reports episodic muscle pain during the past year.

D.   Radiology report identifies no fracture with closed growth plates.

A.   Blood glucose

B.   Renal panel

C.   Electrocardiogram (ECG)

D.   Liver enzymes

A.   Vasopressin nasal spray

B.   Somatropin intramuscular

C.   Desmopressin intravenously

D.   Octreotide subcutaneous

A.   Nausea, Blood glucose elevation, Headache, Low blood pressure

B.   Nausea, Blood glucose elevation, Headache, Low urine output

C.   Low blood pressure, Blood glucose elevation, Headache, Low urine output

D.   Headache, Low urine output, Low blood pressure, Nausea

A.   Limping

B.   Abdominal cramps

C.   Bleeding gums

D.   Excessive thirst

A.   Monitoring the patient in an intensive care unit

B.   Obtaining liver and renal function tests

C.   Co-administering carbamazepine

D.   Administering the vasopressin intravenously

A.   Monitor blood glucose levels closely.

B.   Evaluate the patient for limping.

C.   Monitor fluid status.

D.   Encourage vigorous exercise.

A.   "Shake the medication before administration."

B.   "Heat the medicine before administration."

C.   "Keep the bottle in warm water before administration."

D.   "Do not administer the drug to the patient."

A.   Bleeding gums

B.   Vertigo

C.   Drowsiness

D.   Abdominal stress

A.   Desmopressin

B.   Cosyntropin

C.   Vasopressin

D.   Somatropin

A.   "If it is almost time for your next dose, take a double dose of the drug at that time."

B.   "Skip the missed dose and resume your usual dosage schedule."

C.   "You can take the dose immediately when you remember it."

D.   "You should consult your primary health care provider immediately."

A.   Vasopressin

B.   Somatropin

C.   Desmopressin

D.   Octreotide

A.   Octreotide

B.   Corticotropin

C.   Somatropin

D.   Desmopressin